1 Department of Oncology, University of Lausanne, Lausanne, Switzerland. xuyingxi@ihcams.ac.cn.
2 Ludwig Institute for Cancer Research Lausanne branch, Lausanne, Switzerland. xuyingxi@ihcams.ac.cn.
3 State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin, China. xuyingxi@ihcams.ac.cn.
4 Tianjin Institutes of Health Science, Tianjin, China. xuyingxi@ihcams.ac.cn.
5 State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin, China.
6 Tianjin Institutes of Health Science, Tianjin, China.
7 Department of Oncology, University of Lausanne, Lausanne, Switzerland.
8 Ludwig Institute for Cancer Research Lausanne branch, Lausanne, Switzerland.
9 Graduate Institute of Clinical Medical Sciences, Chang Gung University, Taoyuan, Taiwan.
10 Center for Molecular and Clinical Immunology, Chang Gung University, Taoyuan, Taiwan.
11 Swiss Institute of Bioinformatics, Lausanne, Switzerland.
12 Department of Otolaryngology, National Taiwan University Hospital, Taipei, Taiwan.
13 Chemical Biology Mass Spectrometry Platform (CHEMBIOMS), Faculty of Sciences, University of Geneva, Geneva, Switzerland.
14 Department of Biomedical Sciences, University of Lausanne, Lausanne, Switzerland.
15 Laboratory of Cancer Immunology, Department of Biomedicine, University of Basel and University Hospital of Basel, Basel, Switzerland.
16 Department of Pathology and Immunology, Faculty of Medicine, University of Geneva, Geneva, Switzerland.
17 Geneva Centre for Inflammation Research, Geneva, Switzerland.
18 National Key Laboratory of Immunity and Inflammation, Suzhou Institute of Systems Medicine, Chinese Academy of Medical Sciences & Peking Union Medical College, Suzhou, China.
19 Medical Oncology, University Hospital Basel, Basel, Switzerland.
20 Novogene Co. Ltd, Beijing, China.
21 Institute of Biomedical Sciences, Academia Sinica, Taipei, Taiwan.
22 Taiwan International Graduate Program in Molecular Medicine, National Yang Ming Chiao Tung University and Academia Sinica, Taipei, Taiwan.
23 School of Basic Medical Sciences, Xi'an Jiaotong University, Xi'an, China.
24 Department of Pathology, University of Cambridge, Cambridge, UK.
25 Laboratory of Lymphocyte Signaling and Development, Babraham Institute, Cambridge, UK.
26 Department of Biomedical Engineering, Yale University, New Haven, CT, USA.
27 State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin, China. wangjx@ihcams.ac.cn.
28 Tianjin Institutes of Health Science, Tianjin, China. wangjx@ihcams.ac.cn.
29 Department of Oncology, University of Lausanne, Lausanne, Switzerland. ping-chih.ho@unil.ch.
30 Ludwig Institute for Cancer Research Lausanne branch, Lausanne, Switzerland. ping-chih.ho@unil.ch.
31 College of Medical Science and Technology, Taipei Medical University, Taipei, Taiwan. ping-chih.ho@unil.ch.